AIM ImmunoTech

AIM · NYSE American

$0.1662+$0.0031 (+1.90%)TodayMarket closed ·
Prev close $0.1631

Who owns AIM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 4.5% of AIM’s shares.

  • Jane Street Capital, L.L.C.2.9%
  • Virtu Americas LLC0.4%
  • Equels (Thomas K)0.2%
  • Morgan Stanley & Co. LLC0.2%
  • Next 6 largest institutions0.7%
  • All other shareholders95.5%
Top institutional holders of AIM
HolderShares% of shares
Jane Street Capital, L.L.C.807.88K2.91%
Virtu Americas LLC124.27K0.45%
Equels (Thomas K)63.92K0.23%
Morgan Stanley & Co. LLC50.00K0.18%
Geode Capital Management, L.L.C.46.00K0.17%
Kellner (Theodore D)37.24K0.13%
Goldman Sachs & Co. LLC32.44K0.12%
UBS Financial Services, Inc.28.93K0.10%
Chemerow (David I)28.44K0.10%
Susquehanna International Group, LLP21.86K0.08%

Largest mutual fund holders

Top mutual fund holders of AIM
HolderShares% of shares
Fidelity Extended Market Index Fund44.08K0.16%
Fidelity Series Total Market Index Fund6820.00%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $13.46K (4 trades) of AIM on the open market, with no sales.

Latest AIM insider transactions
InsiderTypeSharesValue
Equels Thomas KBuy24.00K$4.99K
Equels Thomas KBuy11.00K$2.31K
Equels Thomas KBuy22.00K$4.86K
Equels Thomas KBuy5.90K$1.29K

Short interest

Settled Sep 30, 2026

Shares short
1.41M
Days to cover
1.00
% of shares outstanding
5.08%
Average daily volume
1.87M
Change since last report
−49.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.